All News

lumbar,spine,lbp,pain

Which Meds are Best for Acute Low Back Pain?

d EurekAlert!

Acute low back pain (LBP) is a common cause of disability. An analysis in the Journal of Orthopaedic Research examined which non-opioid drugs are best for treating this condition.

Read Article
cost.price_.biologic.injectable.jpg

New Drug Formulations – For Patients or Profits?

d Madelaine Feldman, MD

Wang et al., in a JAMA Network Research Letter, recently reviewed Medicaid expenditures on adalimumab (ADA), sold under the brand name HUMIRA®. They noted that the introduction of the citrate-free formulation cost an extra $4.4B to Medicaid between 2014 and 2021.

Read Article
heavy,metal,sword,knight

Heavy Metals and the Risk of Arthritis

d Jack Cush, MD

The etiology of arthritis was studied using US National Health and Nutrition Examination Survey (NHANES) data and suggested that elevated concentrations of trace elements (TE: Pb, Cd, and Cu) were associated with increased risk of arthritis.

Read Article
RA ILD RTX lung

Specific ACPAs and Autoantibodies Lead to RA-Associated ILD

d Jack Cush, MD

A BRASS registry study shows that specific isotypes of anti-citrullinated protein antibodies (ACPAs) can be associated with incident rheumatoid arthritis-associated ILD (RA-ILD).

Read Article
Have a chance to listen to last week's podcast? Check out our sneak peek and see what Dr. Cush finds surprising. https://t.co/zQIyVWwA8k https://t.co/I3PEUGUx2L

Links:

Dr. John Cush RheumNow ( View Tweet)
Survey of 300 Rheums, GI, Derms - concerns w/ new biosimilars - majority say economics arent favorable to switch to biosimilar - Yet majority "very to somewhat” comfortable w/ biosimilars - US: Slow biosimilar uptake due to disappointing costs https://t.co/6dUR4gA3I5 https://t.co/2bLzE70h6y

Links:

Dr. John Cush RheumNow ( View Tweet)
Im not sure this was necessary but - a metanalysis of 10 RCTs w/ 847 OA patients shows colchicine use in osteoarthritis had no efficacy as far as pain reduction (vs control; SMD= 0.17) & no improvement in function (SMD, - 0.37) https://t.co/67d1ouJyQR https://t.co/6xBJcQCYZt

Links:

Dr. John Cush RheumNow ( View Tweet)
Metanalysis of 25 studies, betw 1985 - 2021, showed US average annual visits for RA=5.25 for US rheums (vs 3.3 ex-US) & 4.8 US non-rheums. SLE=3.24 & 12.3 for US non-Rheums. FM=1.8 for US rheums & 0.4 vs ex-US Rheums. Rheum Visits Decreased 1982 to 2019 https://t.co/5ugk34MJ3b https://t.co/NDMYZT7pil

Links:

Dr. John Cush RheumNow ( View Tweet)
Toxic Epiderman Necrolysis vs Acute Cutaneous Lupus Erythematosus https://t.co/wKX3v01RUb https://t.co/SWwnH7ph04

Links:

Dr. John Cush RheumNow ( View Tweet)
Specific ACPAs and Autoantibodies Lead to RA-Associated ILD https://t.co/KLq3CYc20P https://t.co/G7u36CWOTn

Links:

Dr. John Cush RheumNow ( View Tweet)
EHR study of UK Clinical Practice Research Datalink studied 318 hospitalized gout pts showing there is a 30d increased risk of VTE after gout flare aIRR 2.31 (1.39-3.82), that disappeared 31-90d after. https://t.co/h2v8KbiSwX https://t.co/gsfnR50gTD

Links:

Dr. John Cush RheumNow ( View Tweet)
Vision Loss with ANCA-Associated Vasculitis Shelley K. Dhillon, MD, presents her poster at RWCS 2023. https://t.co/e25SFDXk7O https://t.co/J1AsdE3b0Y

Links:

Dr. John Cush RheumNow ( View Tweet)
Danish Pop. study of frequency of TMJ and oro-facial Dz in 613 pts w/ #JIA followed 4 yrs. Cumulative incidence of TMJ dz was 30%; 21% had arthritis-induced dentofacial deformity & dentofacial dysfunction (52%). TMJ predicted by younger onset, F, ANA+ https://t.co/M39q3snO3n https://t.co/ajPz27lmvt

Links:

Dr. John Cush RheumNow ( View Tweet)
Tigulixostat is a non-purine xanthine oxidase inhibitor studied in 143 gout pts vs PBO with goal of SUA < 5. TIG was effective at 50mg (47%), 100 mg (45% ), 200 mg (62%) vs PBO 2.6% at week 12; w/ more gout flares in PBO Rx pts (13% vs 9%) https://t.co/d9lAjCBUmZ https://t.co/BERW51HW2B

Links:

Dr. John Cush RheumNow ( View Tweet)
PR3 autoreactive CD4+T cells found in affected kidneys of 72 pts with PR3+ ANCA assoc vasculitis. These cytotoxic GPR56+CD4+T cells were significantly greater in those with inactive (vs active GPA), suggesting they may be affected by immunosuppression https://t.co/dHFhgnB8yE https://t.co/ZxV6INeCrU

Links:

Dr. John Cush RheumNow ( View Tweet)
Gingival Inflammation Parallels Saliva “Cytokine Score” Researchers at NYU College of Dentistry have developed a single score to describe the level of cytokines in the saliva, and this score is linked with the severity of clinical gum inflammation. https://t.co/yIk4ddETeh https://t.co/6KNPe77LIV

Links:

Dr. John Cush RheumNow ( View Tweet)
New Laboratory Insights for the ANA+ Consult A new study suggests that use of ELISA assays for CXCL-10 and IFN-α can predict which ANA+ individuals may progress to developing a systemic autoimmune rheumatic disease (SARD). https://t.co/vw4CMf6F0R https://t.co/moJcOr1LYf

Links:

Dr. John Cush RheumNow ( View Tweet)
Differential Dx of Granulomatous Myopathy: Sarcoidosis, inclusion-body myositis, myasthenia gravis, Crohns, GPA, TB, brucellosis, syphilis, PBC, RA, systemic sclerosis , lymphoma, checkpoint inhibitors, GVHD, natural killer/T-cell lymphoma https://t.co/5IUaC1ln7G https://t.co/guYtvyaaHU

Links:

Dr. John Cush RheumNow ( View Tweet)
S.Korean population based study shows the frequency of pregnancy induced de Quervain's tenosynovitis (DQT) between 2013-17 was 2.1% of all preg women. Risk factors: ≥ 30 yrs, multiple gestation, C-Section, HTN in preg, RA (DM not a risk) https://t.co/JaOQhaX5rL https://t.co/cl6RZLfXds

Links:

Dr. John Cush RheumNow ( View Tweet)
IgG4 levels are often elevated and helpful, but not always. @anisha_dua @RWCSmtg @RheumNow #RWCS23 https://t.co/GLPWyXVLgq https://t.co/8rdXpGYWRZ

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×